NCT02144090View on ClinicalTrials.gov

Opsens Optowire for Fractional Flow Reserve - The O2 Pilot Study

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Stable AnginaUnstable Angina PectorisChest PainIschemia
Interventions
DEVICE

Fractional flow reserve measurement

Fractional flow reserve measurement

Trial Locations (1)

G1V 4G5

IUCPQ - Laval Hospital, Québec

All Listed Sponsors
collaborator

Opsens, Inc.

INDUSTRY

collaborator

International Chair on Interventional Cardiology and Transradial Approach

OTHER

lead

Laval University

OTHER

NCT02144090 - Opsens Optowire for Fractional Flow Reserve - The O2 Pilot Study | Biotech Hunter | Biotech Hunter